Researchers investigate NKR antagonists' potential role in breast cancer biology
Audio narration · Coming soon
This research explores the potential role of neurokinin receptor (NKR) antagonists in breast cancer biology. These antagonists are currently used as a nonhormonal treatment for menopausal hot flashes, suggesting a possible new application in cancer treatment.
Why this matters
PRISM scored this story 50/100 for interest.
Originally published by gnews
